# Nifedipine Versus Magnesium Sulfate for Prevention of Preterm Labor in Symptomatic Placenta Previa

> **NCT03542552** · PHASE3 · COMPLETED · sponsor: **Assiut University** · enrollment: 176 (actual)

## Conditions studied

- Placenta Previa

## Interventions

- **DRUG:** Magnesium Sulfate
- **DRUG:** Nifedipine

## Key facts

- **NCT ID:** NCT03542552
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-01
- **Primary completion:** 2021-03-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 176 (ACTUAL)
- **Last updated:** 2021-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03542552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03542552, "Nifedipine Versus Magnesium Sulfate for Prevention of Preterm Labor in Symptomatic Placenta Previa". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03542552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*